Literature DB >> 10867214

How does the apolipoprotein E genotype modulate the brain in aging and in Alzheimer's disease? A review of neuroimaging studies.

M Lehtovirta1, M P Laakso, G B Frisoni, H Soininen.   

Abstract

The epsilon 4 allele of apolipoprotein E is a risk factor for Alzheimer's disease, but also a modulator of its clinical picture. In this paper, recent research in neuroimaging of aging and Alzheimer's disease in relation to apolipoprotein E is reviewed, emphasizing the advances but also the controversies. Further, the possible clinicopathological implications of these findings are discussed.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10867214     DOI： 10.1016/s0197-4580(00)00120-2

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN： 0197-4580            Impact factor:   4.673


  10 in total

1.  Tensor-based morphometry as a neuroimaging biomarker for Alzheimer's disease: an MRI study of 676 AD, MCI, and normal subjects.

Authors:  Xue Hua; Alex D Leow; Neelroop Parikshak; Suh Lee; Ming-Chang Chiang; Arthur W Toga; Clifford R Jack; Michael W Weiner; Paul M Thompson
Journal:  Neuroimage       Date:  2008-07-22       Impact factor: 6.556

2.  Associations between the self-reported frequency of hearing chemical alarms in theater and regional brain volume in Gulf War Veterans.

Authors:  Linda L Chao; Rosemary Reeb; Iva L Esparza; Linda R Abadjian
Journal:  Neurotoxicology       Date:  2016-02-23       Impact factor: 4.294

Review 3.  Annual research review: progress in using brain morphometry as a clinical tool for diagnosing psychiatric disorders.

Authors:  Alexander Haubold; Bradley S Peterson; Ravi Bansal
Journal:  J Child Psychol Psychiatry       Date:  2012-03-07       Impact factor: 8.982

4.  Dopamine transporter genotype predicts implicit sequence learning.

Authors:  Jessica R Simon; Melanie Stollstorff; Lauren C Westbay; Chandan J Vaidya; James H Howard; Darlene V Howard
Journal:  Behav Brain Res       Date:  2010-09-08       Impact factor: 3.332

Review 5.  Magnetic resonance imaging and magnetic resonance spectroscopy in dementias.

Authors:  Y Y Hsu; A T Du; N Schuff; M W Weiner
Journal:  J Geriatr Psychiatry Neurol       Date:  2001       Impact factor: 2.680

Review 6.  Neuroimaging in Alzheimer's disease: relevance for treatment.

Authors:  C H van Dyck
Journal:  Curr Psychiatry Rep       Date:  2001-02       Impact factor: 5.285

7.  Apolipoproteins E and C1 and brain morphology in memory impaired elders.

Authors:  J M Serra-Grabulosa; P Salgado-Pineda; C Junqué; C Solé-Padullés; P Moral; A López-Alomar; T López; A López-Guillén; N Bargalló; J M Mercader; I C Clemente; D Bartrés-Faz
Journal:  Neurogenetics       Date:  2002-12-21       Impact factor: 2.660

8.  Dynamics of gray matter loss in Alzheimer's disease.

Authors:  Paul M Thompson; Kiralee M Hayashi; Greig de Zubicaray; Andrew L Janke; Stephen E Rose; James Semple; David Herman; Michael S Hong; Stephanie S Dittmer; David M Doddrell; Arthur W Toga
Journal:  J Neurosci       Date:  2003-02-01       Impact factor: 6.167

9.  Associations among vascular risk factors, carotid atherosclerosis, and cortical volume and thickness in older adults.

Authors:  Valerie A Cardenas; Bruce Reed; Linda L Chao; Helena Chui; Nerses Sanossian; Charles C DeCarli; Wendy Mack; Joel Kramer; Howard N Hodis; Mingzhu Yan; Michael H Buonocore; Owen Carmichael; William J Jagust; Michael W Weiner
Journal:  Stroke       Date:  2012-09-13       Impact factor: 7.914

10.  Single voxel magnetic resonance spectroscopy at 3 Tesla in a memory disorders clinic: early right hippocampal NAA/Cr loss in mildly impaired subjects.

Authors:  Maria T Caserta; Ann Ragin; Adriana P Hermida; R John Ahrens; Leon Wise
Journal:  Psychiatry Res       Date:  2008-10-19       Impact factor: 3.222
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.